Fever and neutropenia in children with solid tumors is similar in severity and outcome to that in children with leukemia

Supportive Care in Cancer

Volumn 10, Issue 1, 2002, Pages 58-64

  Koçak, Ülker ^a   Rolston, Kenneth V I ^a   Mullen, Craig A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Fever; Leukemia; Malignancy; Neutropenia; Pediatric malignancies

Indexed keywords

AMPHOTERICIN; COTRIMOXAZOLE; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; COMORBIDITY; DEATH; DISEASE SEVERITY; FEBRILE NEUTROPENIA; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SOLID TUMOR;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BLOOD CELL COUNT; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DRUG EVALUATION; FEMALE; FEVER; HUMANS; LEUKEMIA; MALE; NEOPLASMS; NEUTROPENIA; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPECTRUM ANALYSIS; TEXAS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036933356     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200100277     Document Type: Article

References (28)

1. Buchanan GR (1993) Approach to treatment of the febrile cancer patient with low-risk neutropenia. Hematol Oncol Clin North Am 7:919-935
2. Rolston KV, Rubenstein EB, Freifeld A (1996) Early empiric antibiotic therapy for febrile neutropenia patients at low risk. Infect Dis Clin North Am 10:223-237
3. Talcott JA, Siegel RD, Finberg R, Goldman L (1992) Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of prediction rule. J Clin Oncol 10:316-322
4. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J, Rapoport B, Rolston K, Talcott J (2000) The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18:3038-3051
5. Pizzo PA (1993) Management of fever in patients with cancer and treatmentinduced neutropenias. N Engl J Med 328:1323-1332
6. Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, Pizzo P, Rolston KV, Shenep JL, Young LS (1997) Infectious Diseases Society of America 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 25:551-573
7. Mullen CA, Buchanan GR (1990) Early hospital discharge of children with cancer treated for fever and neutropenia: Identification and management of the low-risk patient. J Clin Oncol 8:1998-2004
8. Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, Culbert SC, Danielson M, Jeha S, Kuttesch JF, Rolston KV (1999) Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer 86:126-134
9. Petrilli AS, Dantas LS, Campos MC, Tanaka C, Ginani VC, Seber A (2000) Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: Randomized prospective trial. Med Pediatr Oncol 34:87-91
10. Malik IA (1997) Out-patient management of febrile neutropenia in indigent paediatric patients. Ann Acad Med Singapore 26:742-746
11. Mustafa MM, Aquino VM, Pappo A, Tkaczewski I, Buchanan GR (1996) A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia. J Pediatr 128:847-849
12. Shemesh E, Yaniv I, Drucker M, Hadad S, Goshen Y, Stein J, Ash S, Fisher S, Zaizov R (1998) Home intravenous antibiotic treatment for febrile episodes in immune-compromised pediatric patients. Med Pediatr Oncol 30:95-100
13. Gerberding JL (2000) Preventing antimicrobial-resistant healthcare infections: Beyond 2000. Clin Updates Infect Dis 5:1-4
14. Glauser MP, Calandra T (2000) Infections in patients with hematological malignancies. In: Glauser MP, Pizzo PA (eds) Management of infections in immunocompromised patients. Saunders, New York, pp 141-188
15. Freifeld AG, Walsh TJ, Pizzo PA (1997) Infectious complications in the pediatric cancer patient. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott-Raven, Philadelphia, pp 1069-1114
16. Rolston KVI (2000) Infections in patients with solid tumors. In: Glauser MP, Pizzo PA (eds) Management of infections in immunocompromised patients. Saunders, New York, pp 117-140
17. Hidalgo M, Hornedo J, Lumbreras C, Trigo JM, Colomer R, Perea S, Gomez C, Ruiz A, Garcia-Carbonero R, Cortés-Funes H (1999) Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever. Cancer 85:213-219
18. Kern WV, Cometta A, De BR, Langenaeken J, Paesmans M, Gaya H (1999) Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 341:312-318
19. Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M (1997) A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC trials. Br J Haematol 99:580-588
20. Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, Culbert SJ, Danielson M, Jeha SS, Kuttesch JF, Rolston KV (1999) Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer. J Pediatr Hematol Oncol 21:212-218
21. Lucas KG, Brown AE, Armstrong D, Chapman D, Heller G (1996) The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 77:791-798
22. Mullen CA, Nair J, Sandesh S, Chan KW (2000) Fever and neutropenia in pediatric hematopoietic stem cell transplant patients. Bone Marrow Transplant 25:59-65
23. Rackoff WR, Gonin R, Robinson C, Kreissman SG, Breitfeld PP (1996) Predicting the risk of bacteremia in children with fever and neutropenia. J Clin Oncol 14:919-924
24. Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, Bertolone SJ, McGuire P, Cherlow JM, Tefft M (1995) Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Children's Cancer Group. J Clin Oncol 13:112-123
25. Arndt C, Tefft M, Gehan E, Anderson J, Jenson M, Link M, Donaldson S, Breneman J, Wiener E, Webber B, Maurer H (1997) A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study (IRS) IV pilot study. J Pediatr Hematol Oncol 19:124-129
26. Tubergen DG, Gilchrist GS, O'Brien RT, Coccia PF, Sather HN, Waskerwitz MJ, Hammond GD (1993) Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Children's Cancer Group phase III trial. J Clin Oncol 11:527-537
27. Gaynon PS, Steinherz PG, Bleyer WA, Ablin AR, Albo VC, Finklestein JZ, Grossman NJ, Novak LJ, Pyesmany AF, Reaman GH (1993) Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Children's Cancer Group Study CCG-106. J Clin Oncol 11:2234-2242
28. Gamis AS, Howells WB, DeSwarte-Wallace J, Feusner JH, Buckley JD, Woods WG (2000) Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's Cancer Group study CCG-2891. J Clin Oncol 18:1845-1855